Results 281 to 290 of about 4,079,393 (363)

Characteristics of Swallowing Function in People with Parkinson's Disease: A Scoping Review

Movement Disorders, EarlyView.
Abstract Background Most individuals with Parkinson's disease (PD) develop dysphagia during the course of their disease. It is crucial to comprehensively understand swallowing characteristics specific to PD for effective treatment. Objectives To systematically analyze and synthesize swallowing characteristics in people with PD compared with healthy ...
Kerstin Erfmann, Julia Hirschwald, Jule Hofacker, Katharina Winiker, Juliane Klann, Rainer Dziewas, Tobias Warnecke   +6 more
wiley   +1 more source

Neuromuscular monitoring: An assistant not an alternative.

Indian J Anaesth, 2018
Tak H, Prateek.
europepmc   +1 more source

Neuromuscular Monitoring : A Review [PDF]

, 2006
Babita Ghai, Jeetinder Kaur Makkar, Jyotsna Wig   +2 more
openalex  

MRI of Neurogenic Human Motor Units Following Poliomyelitis

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Surviving motor units in neurogenic diseases demonstrate collateral reinnervation. Scanning electromyography (EMG) reveals normal motor unit corridor length, but with “silent regions,” suggesting that reinnervation does not result in increased motor unit size but may increase motor unit complexity.
Stuart Maitland, Matthew Birkbeck, Ian Schofield, Lawrence Best, James Scott, Andrew Blamire, Roger G. Whittaker   +6 more
wiley   +1 more source

Liver Steatosis in Induced Hepatocytes From Carriers of Spinal Muscular Atrophy

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Although classically characterized as a motor neuron disease, spinal muscular atrophy (SMA) is increasingly recognized as a multisystem disorder. We previously showed hepatocyte‐intrinsic steatosis in SMA, raising the question of whether SMA carriers, who are typically asymptomatic, may also exhibit subclinical hepatic ...
Lingyu Sun, Damien Meng Kiat Leow, Loo Chien Wang, Michelle Yating Eio, Hiromi W. L. Koh, Zi Jian Khong, Gunaseelan Narayanan, Aloysius Kai Soon Teo, Richard Giadone, Radoslaw M. Sobota, Shi Yan Ng, Adrian Kee Keong Teo, Wei Yi Ong, Lee L. Rubin, Basil T. Darras, Crystal J. J. Yeo   +15 more
wiley   +1 more source

Reversal agent is mandatory even with neuromuscular monitoring!

Indian J Anaesth, 2018
Mehandale SG, Bangera A, Thiyath SV.
europepmc   +1 more source

Practical Approach to Managing SCIg Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Guidelines for the management of chronic inflammatory demyelinating polyneuropathy (CIDP) recommend corticosteroids, intravenous immunoglobulin (IVIg), or plasma exchange for first‐line therapies and subcutaneous immunoglobulin (SCIg) as a maintenance option.
Tuan Vu, Claudia Guerra, Niraja Suresh, Sami Khella, Jamie Morrell, Michael Pulley, Nan Jiang, Khema Sharma, Tulio Bertorini, Nivedita Jerath, Amanda Peltier   +10 more
wiley   +1 more source

Clinical Guidelines and Best Practices for Neuromuscular Blockade Monitoring: Ensuring Patient Safety and Optimal Outcomes

Ravi Yadav
openalex   +1 more source

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

Obesity, EarlyView.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden, Maria A. Oquendo, Robert F. Kushner, Dachuang Cao, Chrisanthi A. Karanikas, Afton Kechter, Madhumita A. Murphy   +6 more
wiley   +1 more source

Response to comments on "Reversal agents: Do we need to administer with neuromuscular monitoring".

Indian J Anaesth, 2018
Goyal S, Kothari N, Chaudhary D, Verma S, Bihani P, Rodha MS.   +5 more
europepmc   +1 more source